A B S T R A C T The marrow cells of a patient with pure red cell aplasia markedly increased their rate of heme synthesis when they were freed from the host environment and were incubated in vitro. When the red cell aplasia was treated with cyclophosphamide and prednisone, marrow cell incorporation of 'Fe into heme in vitro increased several weeks before a reticulocytosis was apparent, and was the earliest effect noted. The plasma 'YG-globulins of this patient inhibited heme synthesis by normal marrow cells or the patient's own marrow cells obtained after remission of the disease.
A B S T R A C T The marrow cells of a patient with pure red cell aplasia markedly increased their rate of heme synthesis when they were freed from the host environment and were incubated in vitro. When the red cell aplasia was treated with cyclophosphamide and prednisone, marrow cell incorporation of 'Fe into heme in vitro increased several weeks before a reticulocytosis was apparent, and was the earliest effect noted. The plasma 'YG-globulins of this patient inhibited heme synthesis by normal marrow cells or the patient's own marrow cells obtained after remission of the disease.
Since the inhibition of heme synthesis could be the result of damage to erythroblasts, the patient's posttreatment marrow cells or normal marrow cells were labeled with '9Fe and were then incubated with the patient's pretreatment, treatment, and posttreatment ,YG-globulins as well as normal YG-globulins. At the end of this incubation the supernatant and cells were separated and counted. Heme was extracted and also was counted. Treatment of the cells with the patient's pretreatment YG-globulins resulted in a release of 40% of the radioactive heme from the cells. This represented the loss of radioactive hemoglobin and was an index of erythroblast cytotoxicity. A progressive disappearance of the cytotoxic factor in the YG-globulins occurred in the 3 wk period preceding the onset of reticulocytes in the patient's blood. Posttreatment and normal yG-globulins did not produce this effect and increased injury of red cells and lymphocytes was not produced by the patient's pretreatment yG-globulins. These studies demonstrate a method for measuring erythroblast cytoxicity and show that red cell aplasia is associated with YG-globulins that
INTRODUCTION
Pure red cell aplasia is an' anemia characterized by an almost complete absence of marrow erythroblasts and blood reticulocytes (1, 2) . Other hematopoietic functions such as granulopoiesis and magakaryocytopoiesis appear to be normal, and the marrow has a normal cellularity (1, 2) . This disease is frequently associated with thymomas (1, (3) (4) (5) (6) (7) and has responded to thymectomy (1, 3, 4, 7) , splenectomy (2, 8, 9) , treatment with corticosteroids (2-4, 7) , or with cytotoxic immunosuppressive drugs (10) (11) (12) (13) (14) (15) . Antinuclear antibodies (5, 10, 11, 14, 16, 17) and inhibitors of erythropoiesis (10, 11, 14, 16, 18, 19) have been reported in the plasma of some patients, and a few cases have had a coexistant Coombs positive hemolytic anemia (2, 8, 20) . Because of these observations it has been suggested that pure red cell aplasia might be due to an antibody that prevented normal red cell production (1-3, 5, 6, 8, 10-12, [15] [16] [17] [18] [19] [20] .
We have studied this disease by using a marrow cell culture method in which human marrow responds to the addition of erythropoietin with a marked increase in heme synthesis (21, 22) . These investigations demonstrated an inhibitor of heme synthesis and an antibody to erythroblast nuclei in the yG-globulin fraction of patients with pure red cell aplasia (10, 11, 15) . After a remission of the disease was produced by immunosuppressive drugs, both factors were no longer present (10, 11, 15) . While these observations support the general idea that the disease may be due to an antibody to marrow erythroblasts they do not indicate the precise mechanism by which erythropoiesis is suppressed.
Inhibition of heme synthesis could be due to the prevention of new erythroblast development in vitro or could result from damage to previously formed erythroblasts. By withdrawing blood on a patient prior to treatment and then successfully treating the disease, we proluced a situation in which the patient's pretreatment, treatment, and posttreatment plasma 'G-globulin fractions could be tested on normal marrow, or on his own posttreatment marrow which had an erythroid hyperplasia. Our studies demonstrate that the patient's pretreatment tG-globulins inhibited heme synthesis by his own marrow cells in vitro. In addition, the patient's pretreatment YG-globulins, when incubated with his own marrow cells that had been prelabeled with '9Fe, increased the release of labeled hemoglobin into the medium. When the patient was treated with cyclophosphamide and prednisone the erythroblast cytotoxicity of his YG-globulins progressively disappeared in the 3 wk period before the onset of a reticulocytosis. These experiments demonstrate that erythroblast injury was produced by the patient's YG-globulins prior to treatment and suggest that the reduced erythropoiesis of red cell aplasia might occur through pro(luction of this cytotoxic factor.
METHODS

Case report
The patient (E. M.), a 62 yr old white male, was well until August 1969 when he developed a sinusitis and was found to be anemic. A diagnosis of pure red cell aplasia was made after an examination of the bone marrow revealed virtual absence of erythroblasts with a normal cellularity, normal granulocytopoiesis, and normal megakaryocytopoiesis. The patient had a complete absence of reticulocytes in his blood, but had a normal white cell concentration and slightly elevated platelet concentration. There was no family history of this disorder and no extraordinary contact with toxic chemicals. Physical examination was normal except for a surgical aphakia and glaucoma. Roentgenograms of the chest including laminograms, did not reveal a thymoma. He was treated with 200 mg of pyridoxine and 30 mg of halotestin per day by mouth for 3 months. This was followed by testosterone enanthate 1,200 mg i.m./wk and prednisone 20 mg/day by mouth for another 3 months. At this point the testosterone was discontinued and the patient was treated with 50 mg of prednisone every other day for 4 months, followed by 100 mg every other day for another 4 months. Prolonged treatment with corticosteroids was associated with the onset of glycosuria and a peripheral neuropathy and the prednisone was reduced to 10 mg every other day.
No hematological response was noted with this treatment and in November 1970 the patient was referred to the Vanderbilt University Clinical Research Center. The physical examination was unchanged except for a diffusely enlarged thyroid and slight hepatomegaly. A chest roentgenogram showed slight widening of the superior mediastium which was believed to represent an enlarged thyroid gland after visualization by an -""I scan and aortogram. The blood had a white cell concentration of 6,500/pi with a normal differential count. The platelets were 456,000/pil, but the hematocrit was 21 .6% and no reticulocytes were present. Bone marrow smears and particle sections again showed an almost complete absence of erythroblasts. Blood chemistries were normal except for a slightly elevated glucose and urea nitrogen. The serum thyroxin was normal at 4.4 /Ag/100 ml. Serum electrophoresis revealed a broad increase in the -y-globulins which were 1.9 g/100 ml. Serum complement activity was estimated through measurement of C'3 by the radial immunodiffusion technique (23) using reagents from Hyland1 and it was normal at 163 mg/100 ml. Immunoelectrophoresis of the patient's serum revealed no paraproteins. Plasma erythropoietin, measured by the polycythemic mouse assay (24) was markedly elevated. The Schilling test (25) for vitamin B2 absorption was normal. A tuberculin purified protein derivative (PPD, intermediate strength) skin test was negative.
In vitro heme synthesis Marrow cell cultures. The bone marrow cell cultures were prepared as previously described (21, 22) . Aspirated marrow cells were placed in a sterile tube2 which contained 2 ml of NCTC-109' with heparin (5 U/ml), penicillin (50 U/ml), and streptomycin (2.7 /Ag/ml). The cells were passed through a 10 ml pipette' 10 times to obtain adequate dispersion and were centrifuged for 10 min at 1000 g. The plasma and marrow fat, which floated to the top of the liquid, were removed. The cells were suspended in 5 ml of Hanks' balanced salt solution' with the same concentration of heparin and antibiotics and were recentrifuged. The Hanks' solution was removed and this procedure was repeated three times. The cells were then diluted with a portion of the above NCTC-109 solution and were transferred to 35 X 20 mm tissue culture dishes.2 The culture medium consisted of 60% NCTC-109, 20% normal human plasma from a type AB donor, and 20% sterile-filtered, precolostrum, newborn calf serum.' The cells were incubated at 370C in an atmosphere of 5%o CO2 and 95%o air. Sheep plasma erythropoietin concentrate, 3.3 U/mg protein ( Step III, lot K147 187)f,6 or human urinary erythropoietin concentrate, 65 U/mg protein (Belcher pool H obtained from Dr. Frederick Stohlman, Jr.) were added to the cells as indicated. "9Fe as ferric chloride was attached to transferrin by incubation with a mixture of 60% NCTC-109 and 40% human AB plasma at 370C overnight, and 0.1-0.3 ml of this solution containing 0.4-3.2 ,uCi was added to the cultures.
Cyclohexanione extraction of heme. At the end of an incubation period the contents of the dishes were transferred to glass tubes. The dishes were washed with 2 ml of Bacto Hemagglutination Buffer 7 which was added to the tubes and the latter were centrifuged for 5 min at 1000 g. The supernatants were discarded and the cells were washed once more with 2 ml of this buffer. The packed cells were lysed by the addition of 1.8 ml of Drabkin's solution (26) , diluted to one-third of its usual concentration, and were allowed to stand overnight at 3°. The heme was then extracted from the lysate by the method of Teale (27) as modified by Hrinda and Goldwasser (28) . The lysate was mixed thoroughly with 0.2 ml of 2 N HCl followed by 2 ml of cyclohexanone and the tubes were centrifuged for 30 min at 2000 g. A portion of the upper phase was then counted either in an automatic gamma well-type scintillation counter (Model 4223)8 or at infinite thinness in a gas flow geiger counter with a background of 1.3 cpm (Model 1152). 8 The error in counts per minute was less than 1% (95% confidence level) (29). It has been previously demonstrated that the 'Fe in the upper phase is heme iron (21) . In experiments where several plasmas were utilized the fraction of medium "9Fe incorporated into heme was multiplied by the total iron in the medium to calculate the picograms of iron incorporated into heme. The medium iron was derived entirely from plasma and serum and was determined by the method of Ramsay (30) .
Isolation of hemoglobins and yG-globulins
Carboxy-hemoglobin. The procedure of Huisman, Martin, and Dozy (31) as modified by Fantoni, Bank, and Marks (32) was utilized for the separation of human carboxy-hemoglobin. The patient's marrow cells were incubated with erythropoietin for 72 h before "9Fe was added. The incubation was terminated 10 h later and the marrow cells were transferred to glass tubes and were washed five times as described above with 6 ml of Bacto Hemagglutination Buffer.' The cells were then lysed by being frozen and thawed three times in 4 ml of 0.001 M phosphate buffer, pH 7.3. Carbon monoxide was bubbled through the cell lysates for 10 min and they were dialyzed for 48 h at 30C samples were then counted on 2-inch planchets. Absorbance and counts per minute were doubled to correct for the division of the specimens.
Cyanomethemoglobin. Marrow cells that had been prelabeled with '9Fe for 21 h and then washed free of unincorporated 'Fe, as described below for the measurement of erythroblast cytotoxicity, were lysed in 2 ml of Drabkin's solution diluted to one-third its usual concentration. The lysates remained at 3YC overnight and two were then placed on CM-cellulose columns (0.9 X 25 cm) that had been equilibrated with 0.003 M phosphate buffer which contained 0.11 g/liter sodium bicarbonate, 0.006 g/liter potassium terricyanide, and 0.2 g/liter potassium cyanide. This buffer had a pH of 6.7 and conductivity of 0.5 mmho. The hemoglobin was eluted from the columns at 0.5 ml/min with a conductivity gradient of 0.5-14 mmho using sodium chloride to increase the conductivity. The conductivity gradient was adjusted so that it increased from 0.5-14 mmho over 120 ml of eluate. 4 ml fractions from the columns were tested with a conductivity meter (Type CPM 2d) " and were then analyzed for absorbance at 540 nm and for radioactivity in the well-type scintillation counter. The fractions with a peak at 540 nm were pooled and concentrated to 4 ml by ultrafiltration. The pools were then applied to Sephadex G-200 columns (2.5 X 30 cm) and eluted with the same buffer used to equilibrate the CM-cellulose columns. The void volume and the inner volume of the gel were previously marked with ferritin and glucose as described above. 6-ml fractions were analyzed for absorbance at 540 nm and were then counted in the well-type scintillation counter. The fractions with a peak at 540 nm were once again pooled and concentrated to 4 ml and were then extracted for heme with cyclohexanone along with eight replicate cell lysates that had not been subjected to chromatography.
-yG-globulins. Plasma immunoglobulins were precipitated from 30 ml of plasma with ammonium sulfate at a final saturation of 40%o (34) and were then dialyzed 18 h at 3°C in 400 vol of G.01 M sodium phosphate buffer pH 7.3.
The dialyzed solutions were placed on columns of DEAEcellulose9 (1.5 X 25 cm) that had been equilibrated at 3°C with this buffer (35) . The -yG-globulins were eluted from the DEAE-cellulose at 0.25 ml/min with 0.01 M phosphate buffer, pH 7.3. It has previously been shown that these 'yG-globulin preparations were free of impurities demonstrable by immunoelectrophoresis with 1% agar gel in 0.025 M barbital buffer, pH 8.6, using goat polyvalent anti-human serum'1 as well as rabbit antiserum'2 specific for human yG-globulins (11, 15) . Immunoelectrophoresis of the -yGglobulin fractions used here also revealed no evidence of any impurity. All glassware and columns were cleaned and prepared for tissue culture by the method of Paul (36) .
The purified -yG-globulins were concentrated to 7-8 ml by ultrafiltration with collodion bags9 that had a 25,000 mol wt pore size and had been soaked 24 (37) . Treatment of these yG-globulins with "10-fold" purified rabbit antibody to immunochemically pure human 7S yglobulins 2 was performed after 283 mg of the latter was dissolved in 5 ml Hanks' solution and dialyzed 24 h at 30C in 200 vol of Hanks' solution.7 The rabbit antibody solution was absorbed for 1 h at 260C followed by 6 h at 30C with an equal volume of packed marrow cells that had been washed six times with a total volume of 100 ml of Hanks' solution. It was then centrifuged for 30 min at 300 g and sterilized by passage through a Millipore 0.45 /Am filter. Immunoelectrophoresis as described above using this preparation as antibody and normal human plasma as antigen showed precipitation of only yG-globulins. 12 mg of the absorbed antibody in 0.3 nil of Hanks' solution was added to 38 mg of the patient's yG-globulins in 0.8 ml of NCTC-109. These mixtures remained at room temperature for 1 h followed by 1 h at 30C. They were then centrifuged in 5-ml tissue culture tubes2 for 5 min at 600 g and the supernatants were removed. The precipitates were mixed with 1.7 ml NCTC-109 at 30C and were recentrifuged. The supernatants were combined and were then added to the culture medium and marrow cells. atmosphere. 1 h before terminating the incubation 0.6 uCi of 5'Cr as sodium chromate was added. At the end of an incubation the cells were washed six times with 10 ml of Hanks' solution. The supernatants were counted and the last supernatant had less than 2%o of the radioactivity in the cells. The labeled marrow cells were suspended in Hanks' solution and 0.1 ml of the suspension was transferred to 16 X 125 mm tissue culture tubes to which 0.6 ml NCTC-109 and 0.4 ml fresh frozen human plasma had been added. -yG-globulins were added as a portion of the NCTC-109. The tubes were incubated at 370C for 25 h and were then centrifuged for 5 min at 1000 g. The supernatants were removed from the cells and both were counted in the automatic gamma dual channel well-type scintillation counter8 with the channels set so that no 51Cr cpm were detectable in the "9Fe channel and 12%o of the latter cpm were measured in the 51Cr channel. By the use of 'Fe and 5"Cr standards the precise crossover of 'Fe cpm into the 51Cr channel was measured and subtracted from the apparent 5Cr cpm. The results are expressed as "release index" (RI) 1 (38) : RI = radioactivity of the supernatant X 100 total radioactivity Lymphocyte cytotoxicity. The precedure of Sanderson (39) Sheep plasma erythropoietin (Step III). ¶ Marrow cells aspirated into Hanks' solution with lheparin (5 U/ml), penicillin (50 U/ml), and streptomycin (2.7 gg/ml). patient's plasma for normal plasma produced a 10-fold increase in this rate without the addition of erythropoietin which was already present in high concentration in the patient's plasma. A similar experiment was performed after the marrow cells were aspirated into Hank's solution with heparin and antibiotics and were incubated with only the addition of the patient's plasma. The rate of 'Fe incorporation into heme increased fourfold over a similar period (Table I) .
Measurement of cytotoxicity
Purification of hemoglobin to characterize source of 59Fe. Previous work with normal marrow cells has indicated that the 'Fe which is extracted from the cell lysate by the method of Teale (27) is heme iron (21) and that 93% of the heme radioactivity is derived from hemoglobin (44) . Because of the small number of erythroblasts in the marrow of patients with red cell aplasia it is possible that other iron containing molecules might assume greater relative importance. For this reason, after incubation of the patient's pretreatment marrow with 'Fe, concomitant purification of hemoglobin was performed along with heme extraction. Lysates of cells incubated with and without erythropoietin were chromatographed on CM-cellulose (Fig. 1) . Two large peaks of radioactivity were noted after erythropoietin treatment (Fig. 1B ) that were greatly reduced or not present without the addition of the hormone (Fig.  1A) . In a repeat experiment replicate samples were obtained for heme extraction and for hemoglobin purification by column chromatography (Table II) . The fractions which contained peak I (Fig. 1B) were pooled, concentrated, and mixed with unlabeled ferritin and glucose. This sample was then rechromatographed on Sephadex G-200 (Fig. 1C) The radioactivity of peak I was eluted with the ferritin in the void volume. Peak II has been previously identified as hemoglobin (31) . The fractions which contained peak II (Fig. 1B) were pooled, concentrated, and rechromatographed on a replicate column of Sephadex G-200 (Fig. 1D) . Two additional peaks of radioactivity were noted, peak 1, which was in the void volume and peak 2 which was in the volume occupied by hemoglobin (45) . The specific activity of peak II did not differ from the specific activity of the heme extracted from the unpurified cell lysates with cyclohexanone (Table II) .
Treatment of patient. Because the observations in this case of red cell aplasia were similar to those reported in other cases that had responded to cytotoxic immunosuppressive drugs (10) (11) (12) the patient was treated with cyclophosphamide and prednisone (Fig. 2) . The cyclophosphamide was gradually increased until marrow Eoxicity was reached as indicated by a white cell count of 1500 cells/,l. At this point the cyclophosphamide was discontinued and 20 days later the patient began to have reticulocytes and sustain his red cell mass. He developed disseminated histoplasmosis following this treatment, but this was successfully treated with amphotericin-B. During this treatment repeated bone marrow aspirations were performed and the rate of heme synthesis was measured on the 3rd day of culture. 37 days after beginning treatment a progressive increase in the rate of heme synthesis of the patient's marrow cells was first noted. This occurred before a reticulocytosis was apparent and was the earliest effect of this treatment that was found. The low rates of heme synthesis at 113 and 126 days were probably due to insufficient marrow since the nucleated cell counts were very low at those times. The variation in erythropoietin concentration that was utilized cannot account for more than a 50% variation in heme synthesis (21) . The patient was phlebotomized to remove excess storage iron and maintained a marked erythroid hyperplasia throughout the remainder of his hospital stay.
Effect of patient's yG-globulins on heme synthesis by marrow cells. Frequent blood samples were drawn throughout this investigation and the patient's YG-globulins were purified from these specimens. The patient's pretreatment and posttreatment YG-globulins were then available to test on his own posttreatment marrow cells. When the patient's yG-globulins were incubated with his posttreatment marrow cells (Fig. 3A) , or normal marrow cells (Fig. 3B) , a marked inhibition of heme synthesis was produced by the YG-globulins obtained prior to treatment. The inhibitory capacity of the patient's 'vG-globulins obtained in the 3 wk period between discontinuation of cyclophosphamide and the onset of a reticulocytosis was greatly reduced.
Increasing concentrations of the patient's pretreatment and posttreatment 'YG-globulins were incubated with normal marrow cells in vitro and the effect on the rate of heme synthesis was determined (Fig. 4) . The pretreatment aG-globulins at physiological concentrations markedly inhibited the rate of heme synthesis compared with the posttreatment YG-globulins. Similar results have been obtained when the aG-globulins of another patient with red cell aplasia were compared to normal YG-globulins using normal marrow cells (46) . volume of 0.87 ml with 60% NCTC-109, 20% normal human plasma, and 20% newborn calf serum. Controls (A) had no added hormone; stimulated cultures (B) had 0.6 U/ml of human urinary erythropoietin. After 72 h of incubation 1.8 ,tCi of '9Fe was added and the cultures were terminated 10 h later. Carboxy-hemoglobin was then purified on CMcellulose (A, B). In a repeat experiment (Table II for precise conditions) column peaks I and II from erythropoietin-treated cultures (B) were concentrated. Peak I was combined with unlabeled ferritin and glucose, and was rechromatographed on Sephadex G 200 (C). Peak II was similarly chromatographed on a replicate column (D).
and all of the NCTC-109 media with which each -vGfraction had been dialyzed prior to sterilization. In addition, the YG-globulins of a patient with paroxysmal nocturnal hemoglobinuria (PNH) who had received approximately 10 blood transfusions per year over the preceding 3 yr were tested at the same time. Absorbance at 410 nm multiplied by volume (ml). ¶ From Fig. 1(D) . **P >0.90 (42) .
incubation the cells were separated from the supernatants and the radioactivity was measured. Heme was then extracted from the cells and supernatants and its radioactivity was also measured (Fig. 5) . The pretreatment aG-globulins produced a reduction of cell "Fe compared with the normal 'yG-globulins, the yG-globulins from the patient with PNH, or compared with the range of media against which these various yG-fractions had been dialyzed in their preparation. With the cellular release of 'Fe there was an equal increase in the amount of 'Fe found in the medium. A parallel loss of cell 'Fe- Purification of cyanoinethemnoglobin to characterize source of cell herne "9Fe. Lysates of normal marrow cells labeled with 6"Fe were placed on CM-cellulose columns and hemoglobin was eluted by increasing the conductivity (Fig. 6A ). It has previously been shown that cyanomethemoglobin is eluted with a cyanide buffer system similar to carboxyhemoglobin (47) . The bulk of the radioactivity was associated with the hemoglobin in peak II and that peak was concentrated and placed on G-200 Sephadex columns similar to those used for the purification of carboxyhemoglobin (Fig. 6B) . A single hemoglobin peak of constant specific activity was obtained and no other components containing '9Fe appeared to be present. The specific activity of the 'Fe associated Effect of patient's YG-globulins on lymphocyte cytotoxicity. In order to test the specificity of the patient's pretreatment 'vG-globulins for cellular cytotoxicity, lymphocytes were separated from other blood components and were labeled with 'Cr while marrow cells were labeled with "Fe and "Cr (Table IV) Studies presented here demonstrate that the increase in 59Fe-labeled heme represents an increase in "9Fe-labeled hemoglobin. Culture of these marrow cells with erythropoietin also resulted in an increased incorporation of "9Fe into a non-hemoglobin iron containing fraction of high molecular weight. Hrinda and Goldwasser (28) have shown that erythropoietin stimulates iron incorporation into ferritin in normal rat cells and the large molecular weight of ferritin would place it in this non-hemoglobin fraction. The precise composition of this high molecular weight fraction is not known, however, and it could include other components which contain 'Fe (28) .
When the patient's plasma was substituted for normal plasma the marrow cells also increased their incorporation of 'Fe into heme. It has previously been demonstrated that although the plasma of patients with pure red cell aplasia often contains 'G-globulins that inhibit heme synthesis (11, 15, 46) , the whole plasma may not be inhibitory (11) , especially a small quantity (10) . The precise reason for this is not known, but it may be due to a low plasma concentration of the inhibitor coupled with factors in the plasma that might overshadow or interfere with the action of the inhibitor, such as high erythropoietin levels and, possibly, anticomplementary activity ( 11 ). The patient's marrow cells also increased their rate of incorporation of 59Fe into heme when the cells were incubated in the patient's own plasma that had been diluted with only a balanced salt solution. The smaller increase here, compared with the previous experiment, could be due to the absence of calf serum and NCTC-109, since the former has been shown to potentiate the effect of erythropoietin on marrow cells in vitro (22) , and the latter is an enriched medium. Because the cells were not in contact with any new ingredients except small concentrations of heparin and antibiotics, the increased rate of heme synthesis in this experiment appears to be due to separation of the cells from an inhibitor within the host. In an experiment where the plasma itself was inhibitory it was shown that an increase in the concentration of the plasma in vitro prevented the increase in heme synthesis (10) . In other situations such as this where the whole plasma is not inhibitory it is still possible that inhibition may occur in vivo because larger amounts of the inhibitor are in daily contact with the cells within the host (11) .
When the patient's 'YG-globulins were purified and added to normal marrow cells or his own posttreatment marrow cells under controlled conditions, a marked reduction in the rate of heme synthesis was produced, compared with the effect of his own vG-globulins obtained after treatment or to media that were similarly handled, but did not contain -G-globulins. These studies confirmed that the pure red cell aplasia present in this patient had many of the same characteristics that we have described in other cases (10-12, 15, 46) . He was treated with cyclophosphamide and prednisone and responded like our other patients when he had not responded to prednisone alone in the past. Further investigations were then begun to elucidate the precise Erythroblast Cytotoxicity of yG-Globulins in Pure Red Cell Aplasia mechanism by which the inhibition of heme synthesis was produced.
Incubation of 'Fe-labeled normal marrow cells or the patient's own posttreatment marrow cells with his pretreatment YG-globulins produced a large increase in the release of 'Fe from the cells into the medium. The decrease in cellular 'rFe was directly proportional to the decrease in cellular radioactive heme. When cyanomethemoglobin was purified from the 6'Fe-labeled marrow cells it was evident that the radioactive heme represented 'Fe-labeled hemoglobin. Although a portion of the wFe in the marrow cells was not in hemoglobin the release of 'Fe created by the patient's pretreatment 'iG-globulins was directly proportional, and almost equal, to the release of labeled hemoglobin. Thus the loss of cellular '9Fe or its equivalent appearance in the medium is a measure of the release of hemoglobin from the marrow cells.
The marrow cells were also labeled with "1Cr. Since the number of red cells in the marrow suspension was 100-fold greater than the number of nucleated marrow cells the "1Cr was principally in the red cells (48) while the '9Fe was principally in erythroblasts (49, 50 (48, 51, 52) and is attached nonspecifically to many proteins. The overriding predominance of the red cell concentration allows the use of this isotope for the labeling of red cells in clinical studies (48) . While the patient's pretreatment YG-globulins produced a large increase in the release of '9Fe from the cells into the medium, there was no increase in the release of 51Cr. Thus the patient's -vG-globulins were specifically affecting erythroblasts which contained most of the newly synthesized hemoglobin (53) and were not affecting the red cells which contained most of the 51Cr.
The release of hemoglobin through an action of the patient's 'vG-globulins on erythroblasts is similar to the release of 51Cr-labeled proteins by lymphocytes when they are incubated with antilymphocyte antibodies (39) . The latter effect represents damage to the lymphocytes (54) and has been termed lymphocyte cytotoxicity (39, 41, 55) . We believe the former effect represents injury to erythroblasts and should be termed erythroblast cytotoxicity. Three additional sources of information support this conclusion. In the first place, it has already been demonstrated that specific v-globulins can severely damage red cells (56) or lymphocytes (39, 54, 57) .
Secondly, hemoglobin is almost entirely retained within the red cell membrane which is the basis of all wFe kinetic studies on the survival of these cells (58 (15) . Of the five patients who have had remissions, all had a response of their marrow cells to erythropoietin in vitro which was greater than threefold, while all three of the patients who did not respond had a response of their marrows in vitro which was less than twofold. In all other respects these patients appeared to have the same disease (15) . Thus the response to the hormone in vitro may not only be helpful in studying the pathogenesis of the disease but also in measuring its degree of severity and predicting its response to therapy. As our methods become more refined and the sensitivity to the cytotoxic factor increases, it is hoped that measurement of erythroblast cytotoxicity will provide a better method for identifying the cause of the disease and for following and guiding its treatment.
All of these patients have had an antinuclear antibody to erythroblast nuclei, although some have had antinuclear antibody to lymphocyte nuclei as well (10612, 15, 46) . The relation of this antibody to the 'vG-globulins that injure erythroblasts is not apparent at the present time. It is conceivable that the cytotoxic factor is identical to the antinuclear antibody and that common antigens exist in the nuclear and cytoplasmic membranes. It is also possible, however, that erythroblast cytotoxicity in red cell aplasia leads to immunization by erythroblast nuclei and that the antinuclear antibody arises as a secondary event. Further work is necessary to establish the precise relation which exists between these two factors. Although all of the studies reported here were performed with only one case of pure red cell aplasia, preliminary studies have indicated that yG-globulins which damage erythroblasts occur in other cases as well and that the cytotoxicity is dependent on a heat-labile cofactor which may be complement (6) .
While these investigations are compatable with the idea that erythroblast cytotoxicity is being produced by an antibody, we have no evidence that eliminates the possibility that the cytotoxic factor is an immune complex. Further studies are necessary to characterize the mechanism of action of the vG-globulins and delineate the precise nature of the active molecule. Nevertheless, a system for measuring erythroblast cytotoxicity by vG-globulins has been developed with which it is now possible to explore immune damage to the bone marrow not only in red cell aplasia but in other "refractory anemias." It is conceivable that the mechanism which produces pure red cell aplasia exists in other conditions, but to a lesser degree, and that wider application of these techniques will produce information on another means by which anemia is produced in human beings.
